Organogenesis Holdings Inc (ORGO)
4.05
+0.03
(+0.75%)
USD |
NASDAQ |
Nov 22, 16:00
4.05
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Price to Book Value: 1.928 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.928 |
| November 21, 2024 | 1.913 |
| November 20, 2024 | 1.890 |
| November 19, 2024 | 1.942 |
| November 18, 2024 | 1.875 |
| November 15, 2024 | 1.837 |
| November 14, 2024 | 1.906 |
| November 13, 2024 | 2.108 |
| November 12, 2024 | 1.642 |
| November 11, 2024 | 1.666 |
| November 08, 2024 | 1.561 |
| November 07, 2024 | 1.552 |
| November 06, 2024 | 1.528 |
| November 05, 2024 | 1.447 |
| November 04, 2024 | 1.423 |
| November 01, 2024 | 1.323 |
| October 31, 2024 | 1.318 |
| October 30, 2024 | 1.376 |
| October 29, 2024 | 1.418 |
| October 28, 2024 | 1.404 |
| October 25, 2024 | 1.333 |
| October 24, 2024 | 1.366 |
| October 23, 2024 | 1.376 |
| October 22, 2024 | 1.476 |
| October 21, 2024 | 1.480 |
| Date | Value |
|---|---|
| October 18, 2024 | 1.504 |
| October 17, 2024 | 1.461 |
| October 16, 2024 | 1.547 |
| October 15, 2024 | 1.523 |
| October 14, 2024 | 1.471 |
| October 11, 2024 | 1.461 |
| October 10, 2024 | 1.380 |
| October 09, 2024 | 1.437 |
| October 08, 2024 | 1.423 |
| October 07, 2024 | 1.423 |
| October 04, 2024 | 1.466 |
| October 03, 2024 | 1.361 |
| October 02, 2024 | 1.356 |
| October 01, 2024 | 1.342 |
| September 30, 2024 | 1.361 |
| September 27, 2024 | 1.454 |
| September 26, 2024 | 1.419 |
| September 25, 2024 | 1.394 |
| September 24, 2024 | 1.464 |
| September 23, 2024 | 1.419 |
| September 20, 2024 | 1.424 |
| September 19, 2024 | 1.474 |
| September 18, 2024 | 1.434 |
| September 17, 2024 | 1.464 |
| September 16, 2024 | 1.439 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9332
Minimum
Mar 24 2023
41.55
Maximum
Nov 29 2019
6.048
Average
3.049
Median
Price to Book Value Benchmarks
| Plus Therapeutics Inc | -- |
| Poseida Therapeutics Inc | 3.051 |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.360 |
Price to Book Value Related Metrics
| PS Ratio | 1.182 |
| Price to Free Cash Flow | 138.20 |
| Price | 4.05 |
| Earnings Yield | -1.59% |
| Market Cap | 536.93M |
| Operating PE Ratio | 53.60 |
| Normalized PE Ratio | 56.62 |